Biomarkers: Diabetes, Obesity & Heart

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play a vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of anti-diabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

    Related Conference of Biomarkers: Diabetes, Obesity & Heart

    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 21-22, 2018

    14th World Congress on Endocrinology & Diabetes

    Paris, France
    November 26-27, 2018

    26th International Diabetes and Healthcare Conference

    Helsinki, Finland
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland

    March 28-29, 2019

    21st Asia Pacific Diabetes Conference

    Osaka,Japan
    May 16-17, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Abu Dhabi, UAE

    28th European Diabetes Congress

    June 10-11, 2019 | Edinburgh, Scotland
    July 24-25, 2019

    29th World Diabetes & Heart Congress

    Melbourne, Australia
    Oct 03-04, 2019

    Euro Diabetes Congress & Expo

    | Paris, France

    Biomarkers: Diabetes, Obesity & Heart Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in